Moderate Evidence Research Overview

CJC-1295 Research for Anti-Aging

An evidence-based overview of research examining CJC-1295 in the context of anti-aging. This page synthesizes findings from peer-reviewed literature.

Research Summary

Interest in CJC-1295 for anti-aging stems from the theory that declining GH/IGF-1 levels contribute to aging. The peptide reliably increases these hormones in human studies. Growth hormone affects body composition (reducing fat, maintaining muscle), skin quality, and energy levels. Some anti-aging practitioners use GHRH analogs to restore youthful hormone levels. However, no clinical trials have evaluated CJC-1295 specifically for anti-aging endpoints. The safety of long-term GH elevation is uncertain, with concerns about potential cancer risk from elevated IGF-1.

Referenced Studies

Click any PMID to view the full study on PubMed.

Other Peptides Studied for Anti-Aging

Important Disclaimer

This page summarizes research findings and does not constitute medical advice. CJC-1295 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.